glp-1 next generation glp 1 There's a new name in the conversation — and it's worth paying attention The Next Generation of Weight

As tolerance improves, patients can gradually reintroduce higher-fiber foods and expand dietary variety while monitoring symptoms

A., Evans, S

A similar conversation is now emerging around obesity medicines: GLP-1 and dual agonists are being recognised internationally as evidence-based treatments for obesity with cardiometabolic benefit.[8] Indian insurers may progressively consider coverage when obesity is severe and linked with diabetes, heart disease, or sleep apnoea, rather than for cosmetic weight loss alone.[10] For families, this could mean negotiating group policies and reading the policy wording carefully to see if medically supervised GLP-1 therapy for obesity-with-complications is covered

Niraj Choudhary carefully review potential side effects, monitor your progress, and adjust treatment as needed to ensure safety and effectiveness